撤回：TRIM29通过抑制EZH2的降解促进结直肠癌的进展。

IF 2.8 4区医学 Q2 MEDICINE, RESEARCH & EXPERIMENTAL

Experimental Biology and Medicine Pub Date : 2024-06-10 eCollection Date: 2024-01-01 DOI:10.3389/ebm.2024.10243

引用次数: 0

摘要

[本文撤回了文章 DOI：10.1177/15353702231199070]。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Retraction: TRIM29 promotes the progression of colorectal cancer by suppressing EZH2 degradation.

[This retracts the article DOI: 10.1177/15353702231199070.].

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Experimental Biology and Medicine 医学-医学：研究与实验

CiteScore

6.00

自引率

0.00%

发文量

157

审稿时长

1 months

期刊介绍： Experimental Biology and Medicine (EBM) is a global, peer-reviewed journal dedicated to the publication of multidisciplinary and interdisciplinary research in the biomedical sciences. EBM provides both research and review articles as well as meeting symposia and brief communications. Articles in EBM represent cutting edge research at the overlapping junctions of the biological, physical and engineering sciences that impact upon the health and welfare of the world''s population. Topics covered in EBM include: Anatomy/Pathology; Biochemistry and Molecular Biology; Bioimaging; Biomedical Engineering; Bionanoscience; Cell and Developmental Biology; Endocrinology and Nutrition; Environmental Health/Biomarkers/Precision Medicine; Genomics, Proteomics, and Bioinformatics; Immunology/Microbiology/Virology; Mechanisms of Aging; Neuroscience; Pharmacology and Toxicology; Physiology; Stem Cell Biology; Structural Biology; Systems Biology and Microphysiological Systems; and Translational Research.